• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 1
      Sexual Dysfunction in Those with Androgenetic Alopecia on Dutasteride Versus Finasteride - 16 day(s) ago

      These data highlight the adverse events resulting from the use of dutasteride and finasteride in treating androgenetic alopecia.

      Source: www.hcplive.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	MDMagazine
        MDMagazine

        Among males with androgenetic #alopecia using dutasteride and those using finasteride, new findings suggest that both treatments have similar risks for sexual dysfunction. https://t.co/CAmhSgH1UX

    • Mashup Score: 10
      Table of Contents page: Journal of the American Academy of Dermatology - 2 month(s) ago

      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.

      Source: www.jaad.org
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	AADmember
        AADmember

        A recently published @JAADjournals supplement called “Alopecia: A New Frontier” can help dermatologists differentiate between the various types of #alopecia, identify correct treatments, and earn up to 8 CME credits. https://t.co/JCUW7D1SlV https://t.co/sY1yZI2VRM

    • Mashup Score: 3
      Topline Results Released on IMG-007 Monoclonal Antibody for Alopecia Areata - 2 month(s) ago

      These phase 2a data on IMG-007, a nondepleting anti-OX40 monoclonal antibody, highlight its efficacy among those with alopecia areata.

      Source: www.hcplive.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	MDMagazine
        MDMagazine

        🚨NEW🚨 In new topline data, IMG-007, targeting OX40, showed dose-related hair regrowth and SALT score improvements in severe #alopecia areata patients. Want to learn more?🤔 View here: https://t.co/UyilfoIbfm

    • Mashup Score: 2
      Baricitinib Confirmed Safe and Efficacious for Treating Alopecia Areata - 3 month(s) ago

      Side effects of baricitinib were well within safety parameters, indicating the drug’s viability as a alopecia treatment for adults.

      Source: www.hcplive.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	MDMagazine
        MDMagazine

        A recent study has confirmed the safety and efficacy of baricitinib to treat severe #alopecia in adults. Read more: https://t.co/rXF9Yu54BT https://t.co/ovuRpPcuDG

    • Mashup Score: 3
      Baricitinib Effective in Holistic Responses Among Patients with Alopecia Areata - 3 month(s) ago

      These data highlight the potential impacts of baricitinib across significant hair-bearing areas involved in alopecia areata.

      Source: www.hcplive.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	MDMagazine
        MDMagazine

        In a new study: 🔍Eyebrow and eyelash alopecia severity correlates with scalp #alopecia severity in patients with alopecia areata. 🔍Baricitinib treatment, particularly at 4 mg, significantly improves eyebrow and eyelash regrowth compared to placebo. https://t.co/vxVbwRYUJT

    • Mashup Score: 3
      Baricitinib Effective in Holistic Responses Among Patients with Alopecia Areata - 3 month(s) ago

      These data highlight the potential impacts of baricitinib across significant hair-bearing areas involved in alopecia areata.

      Source: www.hcplive.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	MDMagazine
        MDMagazine

        In a new study: 🔍Eyebrow and eyelash alopecia severity correlates with scalp #alopecia severity in patients with alopecia areata. 🔍Baricitinib treatment, particularly at 4 mg, significantly improves eyebrow and eyelash regrowth compared to placebo. https://t.co/vxVbwRYUJT

    • Mashup Score: 25
      Alopecia – New building blocks - 7 month(s) ago

      Hair loss is devastating to the patient, but the diagnosis and treatment of alopecia are also difficult for primary care providers and even dermatologists. Given recent advances in the field, there has never been a more pressing time to reevaluate and improve upon the significant clinical skills needed to accurately diagnose and treat our patients with hair loss. This CME activity on alopecia is designed to (1) educate dermatologists in a simple, succinct fashion on the identification of, and the distinction between, the diverse types of hair loss and (2) discuss how to manage them.

      Source: www.jaad.org
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	JAADjournals
        JAADjournals

        #Alopecia is devastating for the patient, but the diagnosis and treatment can be difficult for dermatologists as well. This CME activity focuses on the identification of, and distinction between, diverse types of hair loss, with strategies to manage them. https://t.co/zddEIsoMWL https://t.co/U5w6Zs18Q3

    • Mashup Score: 53
      Slowed-down temporal vein refilling as diagnostic pearl in frontal fibrosing alopecia - 7 month(s) ago

      Frontal fibrosing alopecia (FFA) is a primary lymphocytic scarring alopecia with a characteristic clinical pattern of progressive frontotemporal hairline recession and eyebrow loss that mainly affects postmenopausal women.1 Since its first description in 1994, some clinical signs have been added, such as involvement of the beard area or facial papules. In 2015, Vañó et al2 added a new sign: depression of the frontal veins. This clinical sign reflects perivenular fibrosis, with secondary venular dilatation.

      Source: www.jaad.org
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	JAADjournals
        JAADjournals

        This clinical pearl presents a new clinical sign in Frontal fibrosing #alopecia (FFA): slowed-down vein refilling as a diagnostic pearl in FFA. The authors postulate that this sign may help in the clinical diagnosis of this disease. https://t.co/TwfHCW0g7k https://t.co/TiCsAFYH3w

    • Mashup Score: 7
      Alopecia – New building blocks - 8 month(s) ago

      Hair loss is devastating to the patient, but the diagnosis and treatment of alopecia are also difficult for primary care providers and even dermatologists. Given recent advances in the field, there has never been a more pressing time to reevaluate and improve upon the significant clinical skills needed to accurately diagnose and treat our patients with hair loss. This CME activity on alopecia is designed to (1) educate dermatologists in a simple, succinct fashion on the identification of, and the distinction between, the diverse types of hair loss and (2) discuss how to manage them.

      Source: www.jaad.org
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	JAADjournals
        JAADjournals

        This CME activity on #alopecia is designed to educate dermatologists and primary care providers on the identification of, and the distinction between, the diverse types of hair loss and discuss how to manage them. https://t.co/V1lWMiF0uM https://t.co/wwwRKlqEUY

    • Mashup Score: 7
      Alopecia – New building blocks - 9 month(s) ago

      Hair loss is devastating to the patient, but the diagnosis and treatment of alopecia are also difficult for primary care providers and even dermatologists. Given recent advances in the field, there has never been a more pressing time to reevaluate and improve upon the significant clinical skills needed to accurately diagnose and treat our patients with hair loss. This CME activity on alopecia is designed to (1) educate dermatologists in a simple, succinct fashion on the identification of, and the distinction between, the diverse types of hair loss and (2) discuss how to manage them.

      Source: www.jaad.org
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	JAADjournals
        JAADjournals

        This CME activity on #alopecia is designed to educate dermatologists and primary care providers on the identification of, and the distinction between, the diverse types of hair loss and discuss how to manage them. https://t.co/V1lWMiF0uM https://t.co/wwwRKlqEUY

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings